Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Retraction: Cell membrane based biomimetic nanocomposites for targeted therapy of drug resistant EGFR-mutated lung cancer
Nanoscale ( IF 6.7 ) Pub Date : 2022-11-29 , DOI: 10.1039/d2nr90232j Pengying Wu 1, 2 , Dongtao Yin 3, 4 , Jiaming Liu 1 , Huige Zhou 1 , Mengyu Guo 1 , Jing Liu 1, 5 , Yang Liu 3 , Xiaobing Wang 2 , Ying Liu 1 , Chunying Chen 1
Nanoscale ( IF 6.7 ) Pub Date : 2022-11-29 , DOI: 10.1039/d2nr90232j Pengying Wu 1, 2 , Dongtao Yin 3, 4 , Jiaming Liu 1 , Huige Zhou 1 , Mengyu Guo 1 , Jing Liu 1, 5 , Yang Liu 3 , Xiaobing Wang 2 , Ying Liu 1 , Chunying Chen 1
Affiliation
Retraction of ‘Cell membrane based biomimetic nanocomposites for targeted therapy of drug resistant EGFR-mutated lung cancer’ by Pengying Wu et al., Nanoscale, 2019, 11, 19520–19528, https://doi.org/10.1039/C9NR05791A.
中文翻译：
撤稿：基于细胞膜的仿生纳米复合材料用于耐药 EGFR 突变肺癌的靶向治疗
Pengying Wu等人撤回了“基于细胞膜的仿生纳米复合材料用于耐药 EGFR 突变肺癌的靶向治疗” 。,纳米尺度, 2019, 11 , 19520–19528, https://doi.org/10.1039/C9NR05791A。
更新日期：2022-11-29
中文翻译：
撤稿：基于细胞膜的仿生纳米复合材料用于耐药 EGFR 突变肺癌的靶向治疗
Pengying Wu等人撤回了“基于细胞膜的仿生纳米复合材料用于耐药 EGFR 突变肺癌的靶向治疗” 。,纳米尺度, 2019, 11 , 19520–19528, https://doi.org/10.1039/C9NR05791A。
京公网安备 11010802027423号